FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313244546> ?p ?o ?g. }

• W4313244546 endingPage "39" @default.
• W4313244546 startingPage "39" @default.
• W4313244546 abstract "Background and Objectives: Endovascular technologies have significantly improved the outcome of patients with critical limb ischemia (CLI). Drug eluting stents (DES) have documented their efficacy against percutaneous transluminal angioplasty (PTA) and bare metal stents (BMS) in infrapopliteal arterial occlusive disease. However, late in-stent neoatherosclerosis may lead to vascular lumen loss and eventually thrombosis. Polymer free DES constitute a new technology aiming to improve long term patency which their action is still under investigation. The purpose of this study is to report the mechanism of action and to provide a literature review of a novel polymer free amphilimus eluting stent (Cre8, Alvimedica, Instabul, Turkey) in infrapopliteal arterial disease. Methods: Publications listed in electronic databases, European Union Drug Regulating Authorities Clinical Trials Database, as well as scientific programmes of recent interventional vascular conferences were searched. Three studies were included. We analyzed primary and secondary patency, major amputation rate, freedom from CD-TLR, and mortality. Results: Cre8 was implanted in 79 patients with CLI. Most of the patients (n = 65) were Rutherford class 5–6 (82.3%), and diabetes mellitus (DM) was present in 66 patients (83.5%). Mean primary patency was 82.5% at 12 months. Mean lesion stented length was 20 mm and 35 mm in two studies. Mean limb salvage was 91.3% at 12 months. Freedom from CD-TLR was reported in two out of the three studies and was 96% and 83.8%. Mortality was 15% and 23.8% in the same studies, whilst it was not reported in one study. Conclusion: Stenting of infrapopliteal arteries with Cre8 is safe and feasible in patients with CLI and diabetes. All studies have shown very good primary patency and freedom from CD-TLR at 12 and 24 months. Larger observational prospective studies and randomized trials are necessary to establish long term effectiveness and clinical outcomes using the non-polymer Cre8 DES." @default.
• W4313244546 created "2023-01-06" @default.
• W4313244546 creator A5015736219 @default.
• W4313244546 creator A5028737011 @default.
• W4313244546 creator A5042487685 @default.
• W4313244546 creator A5060494582 @default.
• W4313244546 creator A5061171496 @default.
• W4313244546 creator A5080096813 @default.
• W4313244546 creator A5091279861 @default.
• W4313244546 date "2022-12-24" @default.
• W4313244546 modified "2023-10-14" @default.
• W4313244546 title "Polymer Free Amphilimus Drug Eluting Stent for Infrapopliteal Arterial Disease in Patients with Critical Limb Ischemia: A New Device in the Armamentarium" @default.
• W4313244546 cites W139644270 @default.
• W4313244546 cites W1527614413 @default.
• W4313244546 cites W167221777 @default.
• W4313244546 cites W171552336 @default.
• W4313244546 cites W1837848638 @default.
• W4313244546 cites W1968528328 @default.
• W4313244546 cites W1976658801 @default.
• W4313244546 cites W1997207240 @default.
• W4313244546 cites W2013557934 @default.
• W4313244546 cites W2034177980 @default.
• W4313244546 cites W2056680222 @default.
• W4313244546 cites W2083630382 @default.
• W4313244546 cites W2096538171 @default.
• W4313244546 cites W2107933809 @default.
• W4313244546 cites W2108465511 @default.
• W4313244546 cites W2127483273 @default.
• W4313244546 cites W2129371860 @default.
• W4313244546 cites W2133356458 @default.
• W4313244546 cites W2136943950 @default.
• W4313244546 cites W2148374679 @default.
• W4313244546 cites W2162960197 @default.
• W4313244546 cites W2226144646 @default.
• W4313244546 cites W2261230066 @default.
• W4313244546 cites W2300033847 @default.
• W4313244546 cites W2309241745 @default.
• W4313244546 cites W2312530819 @default.
• W4313244546 cites W2327006861 @default.
• W4313244546 cites W2399269337 @default.
• W4313244546 cites W2418123599 @default.
• W4313244546 cites W2506927083 @default.
• W4313244546 cites W2573580372 @default.
• W4313244546 cites W2794425698 @default.
• W4313244546 cites W2889726323 @default.
• W4313244546 cites W2947332499 @default.
• W4313244546 cites W2981564336 @default.
• W4313244546 cites W2989117246 @default.
• W4313244546 cites W3000556138 @default.
• W4313244546 cites W3011835456 @default.
• W4313244546 cites W3106905870 @default.
• W4313244546 cites W3174198306 @default.
• W4313244546 cites W3210128751 @default.
• W4313244546 cites W3214511327 @default.
• W4313244546 cites W39174031 @default.
• W4313244546 cites W4239553742 @default.
• W4313244546 cites W4298148655 @default.
• W4313244546 cites W4302283709 @default.
• W4313244546 cites W2152882707 @default.
• W4313244546 doi "https://doi.org/10.3390/medicina59010039" @default.
• W4313244546 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36676663" @default.
• W4313244546 hasPublicationYear "2022" @default.
• W4313244546 type Work @default.
• W4313244546 citedByCount "1" @default.
• W4313244546 countsByYear W43132445462023 @default.
• W4313244546 crossrefType "journal-article" @default.
• W4313244546 hasAuthorship W4313244546A5015736219 @default.
• W4313244546 hasAuthorship W4313244546A5028737011 @default.
• W4313244546 hasAuthorship W4313244546A5042487685 @default.
• W4313244546 hasAuthorship W4313244546A5060494582 @default.
• W4313244546 hasAuthorship W4313244546A5061171496 @default.
• W4313244546 hasAuthorship W4313244546A5080096813 @default.
• W4313244546 hasAuthorship W4313244546A5091279861 @default.
• W4313244546 hasBestOaLocation W43132445461 @default.
• W4313244546 hasConcept C126322002 @default.
• W4313244546 hasConcept C131631996 @default.
• W4313244546 hasConcept C141071460 @default.
• W4313244546 hasConcept C2776204877 @default.
• W4313244546 hasConcept C2777466421 @default.
• W4313244546 hasConcept C2778283817 @default.
• W4313244546 hasConcept C2778583881 @default.
• W4313244546 hasConcept C2780326628 @default.
• W4313244546 hasConcept C2780400711 @default.
• W4313244546 hasConcept C2780813298 @default.
• W4313244546 hasConcept C2780868729 @default.
• W4313244546 hasConcept C2781099653 @default.
• W4313244546 hasConcept C2781464078 @default.
• W4313244546 hasConcept C3018348675 @default.
• W4313244546 hasConcept C500558357 @default.
• W4313244546 hasConcept C71924100 @default.
• W4313244546 hasConceptScore W4313244546C126322002 @default.
• W4313244546 hasConceptScore W4313244546C131631996 @default.
• W4313244546 hasConceptScore W4313244546C141071460 @default.
• W4313244546 hasConceptScore W4313244546C2776204877 @default.
• W4313244546 hasConceptScore W4313244546C2777466421 @default.
• W4313244546 hasConceptScore W4313244546C2778283817 @default.
• W4313244546 hasConceptScore W4313244546C2778583881 @default.
• W4313244546 hasConceptScore W4313244546C2780326628 @default.

• next